BARD1 also acts as a tumor suppressor in a BRCA1- independent pathway as it interacts with the repeated sequences of the BCL3 ankyrin domains and in turn modulates the activities of transcription factor NFKB in the TP53-dependent apoptotic signaling pathway [34, 35]. The gene discussed is TP53; the disease is neoplasm.